Search results for "Cardiovascular Disease"
ARBs may offer same efficacy, better tolerability than ACE inhibitors
Meta-regression analysis showed that the difference between angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) compared with placebo was due to a higher placebo event rate in the ACE inhibitor trials for the outcome of all-cause mortality, cardiovascular death, and myocardial infarction.
https://immattersacp.org/weekly/archives/2016/01/12/6.htm
12 Jan 2016
Analyses from SPRINT examine cost-effectiveness, patient-reported outcomes with intensive BP control
The first analysis used a microsimulation model to apply findings from SPRINT to a hypothetical cohort of eligible patients. The second compared patient-reported outcomes from SPRINT in the intensive versus the standard treatment group.
https://immattersacp.org/weekly/archives/2017/08/29/2.htm
29 Aug 2017
Managing HIV with testing, prevention
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
https://immattersacp.org/archives/2020/03/managing-hiv-with-testing-prevention.htm
1 Mar 2020
Intensive blood pressure lowering may not induce true kidney disease
The findings can help improve understanding of the significance of creatinine elevations observed during hypertension therapy.
https://immattersacp.org/weekly/archives/2018/10/23/1.htm
23 Oct 2018
LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use
Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018
Label change for pioglitazone-containing medications
This column reviews a label change for medicine that contain pioglitazone and a new indication for empagliflozin.
https://immattersacp.org/archives/2017/02/fda.htm
1 Feb 2017
Balancing benefits and harms of pain meds in older adults
Pain guidelines issued by medical societies call for nondrug therapies and exercise as primary recommendations for chronic pain.
https://immattersacp.org/archives/2023/07/balancing-benefits-and-harms-of-pain-meds-in-older-adults.htm
1 Jul 2023
New guidance urges caution on testosterone
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020
Points to consider in palliative care
An integrated model of curative and palliative care may lead some physicians to reconsider their role in care at the end of life.
https://immattersacp.org/archives/2018/07/points-to-consider-in-palliative-care.htm
1 Jul 2018
Data support targeted approach to cholesterol screening in young adults
The 10-year risk for atherosclerotic cardiovascular disease was less than one half of 1% in nonsmoking, nondiabetic women younger than age 50 years and men younger than age 40 years.
https://immattersacp.org/weekly/archives/2017/05/16/1.htm
16 May 2017